POSTER OF DISTINCTION: RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED PHASE 1 STUDY OF ATH-063: A NOVEL, ORAL, ARTIFICIAL INTELLIGENCE-GENERATED DRUG FOR INFLAMMATORY BOWEL DISEASE.

ATH-63 - Athos Therap

https://crohnscolitiscongress2026.eventscribe.net/ajaxcalls/PresentationInfo.asp?PresentationID=1751356

Allan Pantuck; Iordanis Karagiannidis; David Ho; Phithi Nguyen; Nalin Singh; Georgios Dialynas; Maria-Malvina Tsamouri; Riccardo Calandrelli; Dimitrios Iliopoulos

Jan 27, 2026